MEDS Stock Performance, Insider Transaction and News

MEDS - TRxADE HEALTH, Inc.

Market Cap	7.28M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-19.22M	Forward P/E	-23.76	EPS next Y	-	50D Avg Chg	32.00%
Sales	7.78M	PEG	-	EPS past 5Y	-	200D Avg Chg	47.00%
Dividend	N/A	Price/Book	11.11	EPS next 5Y	-	52W High Chg	-58.00%
Recommedations	2.00	Quick Ratio	4.25	Shares Outstanding	1.41M	52W Low Chg	184.00%
Insider Own	63.99%	ROA	-71.92%	Shares Float	508.99K	Beta	2.17
Inst Own	10.25%	ROE	-269.31%	Shares Shorted/Prior	27.78K/6.91K	Price	10.69
Gross Margin	32.46%	Profit Margin	52.46%	Avg. Volume	659,062	Target Price	-
Oper. Margin	-153.67%	Earnings Date	Aug 16	Volume	8,860,731	Change	61.48%

Healthcare | Pharmaceutical Retailers | United States

About TRxADE HEALTH, Inc.

TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.

TRxADE HEALTH, Inc. News

07/26/24	TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
07/09/24	TRxADE Health, Inc. Announces Special Cash Dividend
07:00 AM	TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale
05/29/24	TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
04/28/24	12 ChatGPT Penny Stock Picks Right Now
04/23/24	TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
01/17/24	Trxade health, Inc files its 3Q 10Q
11/29/23	TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.
10/17/23	TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.
10/12/23	Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales
10/04/23	Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.
09/07/23	TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.
09/07/23	Superlatus Announces Planned Expansion into Pet Food Market
08/24/23	Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
08/22/23	Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
08/14/23	TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
08/03/23	Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
07/31/23	TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time
07/31/23	TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.

MEDS Chatroom

Fredzel Posted - 11 hours ago

$MEDS $PYPD $PMN $NBY $CVM

Ballbustinbucs Posted - 12 hours ago

Stockverified Posted - 12 hours ago

$MEDS

InYourFaceTomSelleck Posted - 13 hours ago

$MEDS sheesh. Whoever bought this at 18-20 a share is getting their asses handed to them. Still want to see where this goes today.

Stockverified Posted - 13 hours ago

$MEDS full float is being traded right now

_StockTrader Posted - 14 hours ago

Real-Time Stock Data $MEDS Price: 13.42 Volume: 725749 Market Cap: 17930962 PE Ratio: -28.333334 Powered by: AITX

MarketDragon Posted - 14 hours ago

Stock Performance for $MEDS over the Last Month: Opening Price: $8.85 Closing Price: $11.63 Highest Price: $23.77 Lowest Price: $8.76 Percentage Change: 31.41% For more information: https://www.sahg6dtr.com/3K2CLMD/R74QP/

topstockalerts Posted - 15 hours ago

$MEDS 400% gain in 6 months. Congrats to all!!

RAPIDTRADX Posted - 15 hours ago

$MEDS KEEP 👀 Can go fast

Orca_Bait Posted - 15 hours ago

$MEDS i see you creepin' back up

seriousrookie Posted - 15 hours ago

$CMAX $CREV $MEDS $WINT Just buy 25 or 50 shares at a time until you get it—nothing beats skin in the game.

Candyman_Trader Posted - 15 hours ago

$CMAX $CREV $MEDS $WINT sooooo glad I respected the plan! As some of you know, i took a 500$ paper account to over 50k$+ twice (2023)... then tried 500$ of real money, got green but the fees ate up ALL gains. (january to march 24) So I figured out, as most do, that 500$ is simply too small and you must be so damn accurate and all-in on every trade. But with 5k$... 🤔 I did a 5k$ paper acct from march to june and grew it over 85k... then another from june 5th to july 12 (5k to >35k$) And now, again with 5k (since july 12 see pic 👇👇👇👇), simply to practice over and over till I get 5k$ of real American cash! 💰 to see if the practice, planning, repetition and strategy pays off, for real!?🤑✌️❤️💰

LewisDaKat Posted - 16 hours ago

$MEDS News out TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million https://marketwirenews.com/news-releases/trxade-health-inc-announces-business-combination-wit-6090915808104051.html $MEDS

Fredo76 Posted - 16 hours ago

$MEDS In at $14.09 wake me up when we hit $20 😴😴😴🛌

bobafiat Posted - 16 hours ago

$MEDS looks good down at these levels expecting a move upwards throughout the day…

BobBuran Posted - 16 hours ago

Friday This is the second of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. PLEASE IGNORE ALL ORDERS MARKED SX SE or LX. Already bot past ten minutes: $RNA $SDST $ORIC $MEDS #stocks

BobBuran Posted - 16 hours ago

Friday This is the first of TWO posts showing a total of about 50 of my buy stop orders (LE for long entry) above the market for today. PLEASE IGNORE ALL ORDERS MARKED SX SE or LX. Already bot past ten minutes: $RNA $SDST $ORIC $MEDS #stocks

_www_larval_com_ Posted - 17 hours ago

$MEDS has jumped 7% higher to 19% (~574Kv) moments ago, follow for more volatility.

Candyman_Trader Posted - 17 hours ago

back at my desk a little late... missed $WINT but it could keep going!? also looking at $CMAX $CREV $MEDS already have a small green morning... not gonna be aggressive today 🤷‍♂️. ✌️❤️💰

Phaws Posted - 17 hours ago

$MEDS shorts selling into bids again to keep it down..lets see what open brings

RallyRaider Posted - 17 hours ago

$MEDS see the chart unless you REAALLY know what youre doing, you re just being toyed around. Wash traded chinese turd

MoonMarket_ Posted - 17 hours ago

I hope you didnt miss $CREV from 9s - link in bio to get in now - spots closing soon $MEDS

StocksSchmocks Posted - 17 hours ago

$MEDS in play

User0199 Posted - 17 hours ago

$MEDS volume is back. njoy the ride up ⏫

dirtfrog Posted - 17 hours ago

$MEDS why does this kind of stuff keep happening after I sold?🥴

7orlo7 Posted - 17 hours ago

$MEDS 🔥

MakingDreamsReality Posted - 17 hours ago

PM mOOvers 👀 $SYTA -Verizon Inks Pact With Siyata Mobile To Launch The Siyata SD7 Push-to-talk Device For First Responders And Enterprise Clients Across The United States. $WINT -Windtree Therapeutics Provides Update On Istaroxime Clinical Development And Business Development $PMN -ProMIS Neurosciences Announces Up To $122.7M Private Placement Financing; Proceeds Expected To Support Company Beyond 6 Month And 12 Month Data From The PMN310 Phase Ib Study In Alzheimer's Patients $MEDS -TRxADE Health Closes Business Combination With Scienture In $103M All-Stock Transactoin; TRxADE Acquired All Of Scienture's Assets In Exchange For TRxADE Shares $CREV -Reported Earlier, Carbon Revolution Teams Up With GM Providing Carbon Fiber Wheels For Chevrolet Corvette ZR1

scalp_scalpnyc Posted - 17 hours ago

$NUZE $SERV $MEDS GET READY $MLGO

Orca_Bait Posted - 18 hours ago

$MEDS adding small

Phaws Posted - 18 hours ago

$MEDS once it finds bottom at open it should run off that news

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
AJJARAPU SURENDRA K	CEO CEO	May 20	Buy	13000	10,000	130,000,000	222,500	05/23/22